Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Cholesterol

The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome

C. J. Walsh; S. Healy; P. W. O’Toole; E. F. Murphy; P. D. Cotter The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome Gut Microbes
Cholesterol Dietary Studies

Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents

P. M. Ryan; E. Patterson; R. M. Kent; H. Stack; P. M. O'Connor; K. Murphy; V. L. Peterson; R. Mandal; D. S. Wishart; T. G. Dinan; J. F. Cryan; R. J. Seeley; C. Stanton; R. P. Ross Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents Sci Rep
Cholesterol

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

T. Kyaw Tun; A. McGowan; N. Phelan; N. Correia; G. Boran; A. L. O'Connor; H. M. Roche; J. Gibney Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome Int J Endocrinol
Cholesterol Insulin resistance & diabetes PCOS

Low-Carbohydrate Diets in the Management of Obesity and Type 2 Diabetes: A Review from Clinicians Using the Approach in Practice

T. Kelly; D. Unwin; F. Finucane Low-Carbohydrate Diets in the Management of Obesity and Type 2 Diabetes: A Review from Clinicians Using the Approach in Practice Int J Environ Res Public Health
Cholesterol Medications T2DM Weight loss / Management

A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes

J. A. Daniels; C. Mulligan; D. McCance; J. V. Woodside; C. Patterson; I. S. Young; J. McEneny A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes Cardiovascular diabetology
Cholesterol T2DM

Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism

S. Curley; J. Gall; R. Byrne; L. Yvan-Charvet; F. C. McGillicuddy Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism Mol Nutr Food Res
Cholesterol Medications

Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity

M. Murray; A. L. Dordevic; K. H. M. Cox; A. Scholey; L. Ryan; M. P. Bonham Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity BMJ Open
Cholesterol Mental Health

Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages

M. E. O'Reilly; S. Kajani; J. C. Ralston; Y. M. Lenighan; H. M. Roche; F. C. McGillicuddy Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages Mol Nutr Food Res
Cholesterol

Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways

M. E. O'Reilly; Y. M. Lenighan; E. Dillon; S. Kajani; S. Curley; R. Bruen; R. Byrne; A. M. Heslin; A. P. Moloney; H. M. Roche; F. C. McGillicuddy Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein Pathways Mol Nutr Food Res
Cholesterol Medications

Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study

E. M. Yubero-Serrano; J. Delgado-Lista; A. C. Tierney; P. Perez-Martinez; A. Garcia-Rios; J. F. Alcala-Diaz; J. P. Castaño; F. J. Tinahones; C. A. Drevon; C. Defoort; E. E. Blaak; A. Dembinska-Kieć; U. Risérus; J. A. Lovegrove; F. Perez-Jimenez; H. M. Roc Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study Am J Clin Nutr
Cholesterol Insulin resistance & diabetes Metabolic Syndrome

Older posts

Page1 Page2 … Page10 Next →

Search for:

Recent Posts

ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!
“Addressing Obesity Together” – Press Release

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Privacy Policy
Site Map

©2023 ASOI